PLUR
Price
$4.47
Change
-$0.08 (-1.76%)
Updated
Aug 12, 11:43 AM (EDT)
Capitalization
35.81M
RZLT
Price
$6.16
Change
+$0.22 (+3.70%)
Updated
Aug 12, 12:27 PM (EDT)
Capitalization
516.15M
30 days until earnings call
Interact to see
Advertisement

PLUR vs RZLT

Header iconPLUR vs RZLT Comparison
Open Charts PLUR vs RZLTBanner chart's image
Pluri
Price$4.47
Change-$0.08 (-1.76%)
Volume$332
Capitalization35.81M
Rezolute
Price$6.16
Change+$0.22 (+3.70%)
Volume$863
Capitalization516.15M
PLUR vs RZLT Comparison Chart in %
Loading...
PLUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLUR vs. RZLT commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLUR is a Hold and RZLT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (PLUR: $4.55 vs. RZLT: $5.93)
Brand notoriety: PLUR and RZLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLUR: 15% vs. RZLT: 51%
Market capitalization -- PLUR: $35.81M vs. RZLT: $516.15M
PLUR [@Biotechnology] is valued at $35.81M. RZLT’s [@Biotechnology] market capitalization is $516.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.01B to $0. The average market capitalization across the [@Biotechnology] industry is $1.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLUR’s FA Score shows that 0 FA rating(s) are green whileRZLT’s FA Score has 0 green FA rating(s).

  • PLUR’s FA Score: 0 green, 5 red.
  • RZLT’s FA Score: 0 green, 5 red.
According to our system of comparison, RZLT is a better buy in the long-term than PLUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLUR’s TA Score shows that 3 TA indicator(s) are bullish while RZLT’s TA Score has 4 bullish TA indicator(s).

  • PLUR’s TA Score: 3 bullish, 5 bearish.
  • RZLT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RZLT is a better buy in the short-term than PLUR.

Price Growth

PLUR (@Biotechnology) experienced а -15.11% price change this week, while RZLT (@Biotechnology) price change was +0.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.53%. For the same industry, the average monthly price growth was +20.28%, and the average quarterly price growth was +17.63%.

Reported Earning Dates

RZLT is expected to report earnings on Sep 11, 2025.

Industries' Descriptions

@Biotechnology (+7.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RZLT($516M) has a higher market cap than PLUR($35.8M). RZLT YTD gains are higher at: 21.082 vs. PLUR (6.433). PLUR has higher annual earnings (EBITDA): -20.22M vs. RZLT (-77.12M). RZLT has more cash in the bank: 86.9M vs. PLUR (26.3M). RZLT has less debt than PLUR: RZLT (1.78M) vs PLUR (31.2M). PLUR has higher revenues than RZLT: PLUR (1.03M) vs RZLT (0).
PLURRZLTPLUR / RZLT
Capitalization35.8M516M7%
EBITDA-20.22M-77.12M26%
Gain YTD6.43321.08231%
P/E RatioN/AN/A-
Revenue1.03M0-
Total Cash26.3M86.9M30%
Total Debt31.2M1.78M1,758%
FUNDAMENTALS RATINGS
PLUR vs RZLT: Fundamental Ratings
PLUR
RZLT
OUTLOOK RATING
1..100
5356
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6439
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RZLT's Valuation (53) in the null industry is somewhat better than the same rating for PLUR (98) in the Biotechnology industry. This means that RZLT’s stock grew somewhat faster than PLUR’s over the last 12 months.

RZLT's Profit vs Risk Rating (100) in the null industry is in the same range as PLUR (100) in the Biotechnology industry. This means that RZLT’s stock grew similarly to PLUR’s over the last 12 months.

RZLT's SMR Rating (98) in the null industry is in the same range as PLUR (100) in the Biotechnology industry. This means that RZLT’s stock grew similarly to PLUR’s over the last 12 months.

RZLT's Price Growth Rating (39) in the null industry is in the same range as PLUR (64) in the Biotechnology industry. This means that RZLT’s stock grew similarly to PLUR’s over the last 12 months.

RZLT's P/E Growth Rating (100) in the null industry is in the same range as PLUR (100) in the Biotechnology industry. This means that RZLT’s stock grew similarly to PLUR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PLURRZLT
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 1 day ago
88%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PLUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FKIDX16.92N/A
N/A
Fidelity Diversified Intl K6
BUFMX16.66N/A
N/A
Buffalo Mid Cap Growth
MASPX28.97N/A
N/A
BlackRock Advantage SMID Cap Instl
SBQAX13.79N/A
N/A
AmericaFirst Alpha Trends Factor Class A
BISMX25.54-0.13
-0.51%
Brandes International Small Cap Equity I

PLUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLUR has been loosely correlated with RZLT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PLUR jumps, then RZLT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLUR
1D Price
Change %
PLUR100%
-5.52%
RZLT - PLUR
34%
Loosely correlated
+2.12%
KOD - PLUR
29%
Poorly correlated
+1.65%
RLMD - PLUR
28%
Poorly correlated
-4.14%
BEAM - PLUR
25%
Poorly correlated
-2.58%
CSBR - PLUR
25%
Poorly correlated
+1.87%
More

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been loosely correlated with RLAY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RZLT jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
+2.12%
RLAY - RZLT
46%
Loosely correlated
+0.62%
XNCR - RZLT
45%
Loosely correlated
-3.18%
ATYR - RZLT
41%
Loosely correlated
+7.06%
SYRE - RZLT
40%
Loosely correlated
+0.07%
CRNX - RZLT
40%
Loosely correlated
+2.05%
More